Daxor Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in New York City, New York. Daxor Corporation is a diversified, closed-end management investment company. Its focus and operations are as a medical device manufacturing, company. The company specializes in blood volume measurement technology focused on blood volume testing innovation. The company markets the Blood Volume Analyzer (BVA)-100, the diagnostic blood test cleared by the FDA to provide objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000 tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including reducing mortality and readmissions in heart failure and critical care. Its facility provides on-demand, next day blood volume analysis results. The company has several ongoing trials in the areas of heart failure treatment with support from the NIH and is under contract developing analyzers to improve combat casualty care with the United States Department of Defense.
Follow-Up Questions
What is Daxor Corp (DXR)'s P/E Ratio?
The P/E ratio of Daxor Corp is 108.1778
Who is the CEO of Daxor Corp?
Mr. Michael Feldschuh is the Chairman of the Board of Daxor Corp, joining the firm since 2013.
What is the price performance of DXR stock?
The current price of DXR is $11.4, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Daxor Corp?
Daxor Corp belongs to Health Care industry and the sector is Health Care
What is Daxor Corp market cap?
Daxor Corp's current market cap is $56.7M
Is Daxor Corp a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Daxor Corp, including 1 strong buy, 4 buy, 1 hold, 0 sell, and 1 strong sell
